13F-HR filed by Kynam Capital Management, LP
Kynam Capital Management, LP filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 37 holding rows worth $474,567,000.
- Accession
- 0001085146-22-004005
- Filer
- CIK 1907884
- Filed
- 2022-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2022
A holdings report, 37 entries on the cover page, a total value of $474,567,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $474,567,000 with VALUE read as thousands by filing date, 13F file number 028-21939. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NATERA INC COM | 632307104 | Stock | 2,018,360 | $88,445,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 2,272,915 | $54,618,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 1,600,127 | $44,980,000 | thousands by filing date | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 1,536,181 | $32,736,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 151,009 | $31,618,000 | thousands by filing date | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 600,000 | $22,812,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,000,000 | $20,510,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 75,000 | $20,025,000 | thousands by filing date | |
| VAXCYTE INC COM | 92243G108 | Stock | 698,638 | $16,767,000 | thousands by filing date | |
| BURNING ROCK BIOTECH LTD | 12233L107 | SPONSORED ADS | 6,703,863 | $16,022,000 | thousands by filing date | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 500,000 | $14,715,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 985,155 | $14,699,000 | thousands by filing date | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 1,673,041 | $11,209,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 416,729 | $10,268,000 | thousands by filing date | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 1,692,402 | $9,207,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 131,220 | $8,936,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 6,720,148 | $7,325,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 676,849 | $7,066,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 435,117 | $5,482,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 1,397,479 | $5,045,000 | thousands by filing date | |
| SERES THERAPEUTICS INC | 81750R102 | COM | 772,820 | $4,962,000 | thousands by filing date | |
| AKOUOS INC | 00973J101 | COM | 718,394 | $4,856,000 | thousands by filing date | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 386,349 | $4,628,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 519,212 | $4,377,000 | thousands by filing date | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 1,399,633 | $3,863,000 | thousands by filing date | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 731,521 | $2,941,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 676,675 | $1,394,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 559,769 | $1,327,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 28,792 | $1,039,000 | thousands by filing date | |
| CONNECT BIOPHARMA HLDGS LTD | 207523101 | SHS | 739,649 | $954,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 300,000 | $803,000 | thousands by filing date | put |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 527,805 | $343,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 260,000 | $338,000 | thousands by filing date | call |
| TRICIDA INC | 89610F101 | COM | 97,600 | $122,000 | thousands by filing date | put |
| NEOLEUKIN THERAPEUTICS INC | 64049K104 | COM | 120,368 | $77,000 | thousands by filing date | |
| CATALYST BIOSCIENCES INC | 14888D208 | COM | 90,188 | $45,000 | thousands by filing date | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 507,700 | $13,000 | thousands by filing date | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-22-004005 | this filing | 2022-11-14 | acceptance time not in the bulk data set |